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Abstract
Background: Several studies have compared nasal swabs to the more invasive nasopharyngeal aspirate (NPA) for
detection of respiratory viruses. Mostly, the comparisons have been performed on immunocompetent children
with upper respiratory tract symptoms. The results range from a relatively poor sensitivity for the swabs to an even
higher sensitivity than for the NPA. We aimed to investigate the sensitivity of a flocked nasal swab (fNS) on
immunocompromised adults with febrile neutropenia.
Methods: During 16 months, adults with a hematological disorder presenting with febrile neutropenia were
enrolled in the study. Paired samples of the fNS and NPA were collected in the outer part of the nasal cavity and
the nasopharynx, respectively. The samples were analyzed regarding a panel of 15 respiratory viruses by means of
quantitative polymerase chain reaction. Furthermore, as an indirect measure of cell yield by either method, the
copy number of the human beta actin gene was also determined. Cohen’s kappa was calculated as a measure of
agreement of the results obtained from either method. Wilcoxon signed-rank test was used for comparison of cell
yield.
Results: A total of 98 paired samples from a total of 89 patients were collected. Twenty of the pairs had virus
detected in at least one of the specimens; 11 in both, 7 in NPA only, and 2 in fNS only. For the fNS, the overall
sensitivity for any virus and for rhinovirus only was 65% and 78%, respectively. NPA was significantly superior to
the fNS in collecting epithelial cells.
Conclusion: We found the overall sensitivity of 65% to be too low to replace NPA with this sampling technique in
this patient category.
Background
A number of studies have compared different sampling
techniques for detection of viruses in the upper respira-
tory tract in immunocompetent children [1-14]. The
advantages of using a swab in the nares compared to
nasopharyngeal aspirate (NPA) are for the patient less
discomfort and more rapid sampling procedure. For the
medical personnel there is a time gain. Finally, the swab
goes with a lower cost than does the NPA. Respiratory
viruses are common findings in children [15] and adults
with hematological malignancies and have been recog-
nized as a potential cause of pneumonia and death [16].
Thus, the sampling frequency for detection of respira-
tory viruses in this patient category is expected to
increase. However, most of the studies comparing sam-
pling techniques are performed on children and, as to
our knowledge; to date no study has been performed on
immunocompromised individuals which could have
a reduced local immunological and inflammatory
response, making a direct clinical application of to date
achieved results and conclusions impossible. As the
swab has been suggested to be comparable with
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determine the sensitivity of detecting respiratory viruses
in immunocompromised adults using a flocked nasal
swab (fNS) in the outer part of the nose cavity com-
pared to NPA.
Methods
Participants
Between January 2008 and May 2009 adults with any
hematological disorder presenting at the Karolinska Uni-
versity Hospital, Stockholm, for febrile neutropenia
(auricular temperature >38.0°C twice or ≥38.5°C at
one occasion, and an absolute neutrophil count
≤500 cells/mm
3) were asked to participate in this study.
The patients were allowed to participate more than
once provided that an afebrile period of at least three
weeks separated the episodes of febrile neutropenia. At
admission, the patients received empirically admini-
strated broad-spectrum antibiotics; ceftazidime or piper-
acillin-tazobactam.
Collection and storage of material
The collection was made within 72 hours from onset of
f e v e r .T h ef N Sw i t han y l o nf i b e rt i p( C O P A N ,a r t .n o .
CP552C) was inserted at least 20 mm and rotated inside
each nostril. Then, the NPA was obtained by insertion of
a sterile catheter (no. 8, Mediplast, Sweden) into the pos-
terior nasopharynx and pulled back while applying gentle
suction. Finally, 2-3 mL of sodium chloride was sucked
into the trap. Both specimens were obtained without
instillation of any solution into the nostrils. The speci-
mens were stored without any medium in room tempera-
ture and transported to the laboratory within six hours.
The NPA was stored in its collection tube in minus 80°C.
The fiber tip of the fNS was put in 500 μL RPMI 1640
(Sigma-Aldrich, St. Louis, MO) and shaken for 30 min-
utes. The suspension was stored in minus 80°C.
Detection methods
A total of 400 μL of each sample was extracted and then
analyzed regarding presence of nucleic acids from ade-
novirus, bocavirus, coronavirus, enterovirus, influenza-
virus A+B, metapneumovirus, parainfluenzavirus 1-3,
rhinovirus, and RS-virus. The extraction method and
the quantitative polymerase chain reaction (qPCR) assay
are previously described [10]. A TaqMan qPCR
assay was developed based on amplification of the
human beta actin gene (ACTB) (forward primer
5’-GCGCGGCTACAGCTTCA-3’ [50 nM], reverse pri-
mer 5’-GCGCGGCTACAGCTTCA-3’ [900 nM], probe
6FAM-CACCACGGCCGAGC-MGB [150 nM]). The
assay was performed on an ABI 7500 Real-Time PCR
System (Applied Biosystems). The PCR assay was car-
ried out in a total 50-μL reaction mixture containing
25 μL of TaqMan Universal PCR Master Mix (Applied
Biosystems) and 5 μL of template, leaving 20 μLt ot h e
primers and probe. The PCR program included 1 cycle
at 50°C for 2 min, 1 cycle at 95°C for 10 min, followed
by 40 cycles consisting of 15 sec at 95°C and 60 sec at
60°C. The sensitivity of the assay was 3 copies per reac-
tion, as determined by repeated testing of in-house
cloned plasmids.
Ethics
After giving written informed consent the patients were
enrolled. The study was approved by The Regional Ethi-
cal Review Board in Stockholm that handles applications
for research at Karolinska University Hospital.
Statistical methods
Positivity by either method was used as gold standard
for presence of viruses. Cohen’s kappa was calculated as
a measure of agreement of the results obtained from
either method [17]. Wilcoxon signed-rank test and Pear-
son’s correlation coefficient were used when appropriate.
Age is presented as means ± SD, whereas neutrophil
count is presented as median followed by range.
A p-value < 0.05 was considered significant. InStat 3.05
and Prism 5.00 for Windows were used.
Results
A total of 98 episodes of febrile neutropenia occurring
in 89 patients were included in the study. Based on epi-
sodes, the mean age was 55 ± 15 years (43 females, 57 ±
13 years; 55 males, 53 ± 16 years) and the median neu-
trophil count <100 cells/mm
3 (<100-500). As underlying
hematological disorder, acute leukemia and myelodys-
plastic syndrome predominated (n = 42, 43%) followed
by non-Hodgking lymphoma (n = 33, 34%) and mye-
loma (n = 13, 13%). The remaining diagnoses were
chronic lymphocytic leukemia (n = 6, 6%) and Hodgk-
ing’s lymphoma (n = 4, 4%). In total, 49 (50%) of the
patients were on antiviral prophylaxis with aciclovir.
The patients were sampled within one day from admit-
tance (n = 54, 55%), but due to practical obstacles, in 32
(33%) and 9 (9%) of the cases, the samples were col-
lected on the second and third day after admittance,
respectively. In total, 98 paired samples collected with
fNS and NPA respectively, were obtained. A total of 20
of the pairs had virus detected in one or both of the
specimens; 7 exclusively in NPA and 2 exclusively in
fNS (Table 1). The sensitivity for the fNS in detection of
any virus was 65% (95% CI = 41-85) and for rhinovirus
78% (95% CI = 40-97). The positivity rates for any virus
for the NPA and fNS were 18.4% (18 of 98) and 13.3%
(13 of 98), respectively, showing a “substantial” agree-
ment (for rhinovirus an “almost perfect” agreement)
according to Landis and Koch’s scale [17].
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ACTB copy numbers was significantly larger than by
fNS with a mean difference of 4.2 × 10
5 cells/mL (p =
.001). In pairs with virus detected in both methods, the
Ct values were lower (thus viral load higher) for NPA
than for fNS. We plotted the difference in cell count
between fNS and NPA against the difference in Ct
values between the methods for the positive pairs.
Although not statistically significant, the correlation
indicate a possible association between a high cell yield
and low Ct value (r = -0.46, p = .15).
Discussion
We compared the efficacy to collect specimen for viral
detection between fNS and NPA. According to Landis
and Koch’s [17] scale there was a substantial agreement
between the methods, to NPA’s favor, and NPA was sig-
nificantly more efficient collecting epithelial material
approximated by quantification of ACTB. Even if
removal of the cellular component of NPA does not
interfere with quantification of some respiratory viruses
[18], a higher cell count might indicate a higher yield of
specimen. Even though not statistically significant, the
Ct value negatively correlated to the number of cells
collected, and thus, the finding of NPA being superior
to the fNS in collecting cells invite us to speculate that
the fNS sometimes may collect inadequate amount of
specimen in order to reach the PCR method’s detection
limit. Furthermore, several reports have suggested that
sensitivity increases when the nasopharynx is sampled
instead of the nasal cavity [2,5,11,14].
Thus, the difference in sensitivity for the fNS and
NPA could have several reasons; biological and techni-
cal. One obvious biological reason is the fact that two
different anatomical sites are investigated; one technical
explanation could be that suction is superior scratching
for collecting adequate amount material. The production
of mucus that transports the viral nucleic acids in an
anterior direction to the fNS’s sampling site may be an
important parameter. In this patient category, the lack
of a competent immune response could reduce the
mucus-production. Taking the above into account, the
depth of the sampling with the fNS probably plays an
important role. However, a deeper penetration could
cause even more discomfort than does the NPA.
In contrast to our findings, several groups have
reached good sensitivity using the fNS in the outer part
of the nose and concluded it comparable to NPA [1,4,9].
Sung et al who used an insertion depth of only 1-1.5 cm
s u m m a r i z e dt h ef N Sa ne v e nb e t t e ro p t i o nw h e nu s i n g
PCR.
This study has several limitations. The time interval
between fever onset and sampling varied between the
patients, and they did not necessarily have respiratory
tract symptoms. Furthermore, the patients suffered from
different underlying diseases. However, this reflects the
clinical reality and as both sampling methods were used
at the same time point in the same patient, the compari-
son is still valid. The foremost important limitation is
the low number of positive samples on which the calcu-
lation of sensitivity is based. However, the upper limit in
the 95% confidence interval for the overall sensitivity
was 85% which is still a questionable value for replacing
an established method.
In summary, the NPA was superior to the fNS in col-
lecting epithelial cells. Furthermore, we also found lower
sensitivity for the fNS than for NPA in detecting
respiratory viruses in these immunocompromised adults.
Table 1 Detection of viruses in NPA and fNS specimens compared with total viral findings by either method
Virus No. of samples in which
virus was detected by:
Total
no.
Sensitivity
a for
fNS (%)
Mean difference
b in Ct
values (range)
Agreement
c between NPA and
fNS (95% CI
d)
Both
methods
NPA
only
fNS
only
Rhinovirus 7 2 0 9 78 3.2 (-2.0-6.5) 0.86 (0.68-1.05)
RSV A 1 1 1 3 5.8
RSV B 2 0 0 2 2.2 (5.6-9.9)
Influenza A 0 1 0 1 N/A
Influenza B 1 1 0 2 15.5
Bocavirus 0 1 0 1 N/A
Enterovirus 0 1 0 1 N/A
Metapneumovirus 0 0 1 1 N/A
Any virus 11 7 2 20 65 5.1 (-2.0-15.5) 0.66 (0.44-0.87)
NOTE. NPA, nasopharyngeal aspirate; fNS, flocked nasal swab; Ct, cycle of threshold; CI, confidence interval.
a Percentage of positive samples from fNS in relation to the total number of pairs with positive results from any of specimens.
b The Ct value for the flocked nasal swab minus the corresponding Ct value for NPA.
c Cohen’s kappa: >0.8, almost perfect agreement; 0.6-0.8, substantial agreement; 0.4-0.6, moderate agreement; <0.4, poor agreement.
d CI, confidence interval.
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Page 3 of 4For detection of rhinovirus it was slightly better, but still
not appropriate, according to our judgment, for clinical
use in this patient category. With an insertion depth
comparable to what other groups have used we found
lower sensitivity for the fNS than previous investigators.
Less mucus production and consequently less anterior
transport of viral nucleic acid in immunocompromised
individuals may explain this finding.
Conclusions
On the basis of our findings, fNS sampling of the nares
for viral detection in immunocompromised individuals
cannot be recommended until further large studies have
revealed more promising results.
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